CD69 and glioblastoma: In our analysis, cells positive for the CD8, CD103, and CD69 surface markers (which define the phenotype of the CD8+ TRM lymphocytes) were detected in the GBM sample and were counted as 15 cells in the selected area, while CD8+ TRM cells were absent from meningioma samples.